1. Home
  2. EOLS vs LFCR Comparison

EOLS vs LFCR Comparison

Compare EOLS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.01

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Logo Lifecore Biomedical Inc.

LFCR

Lifecore Biomedical Inc.

HOLD

Current Price

$3.65

Market Cap

269.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EOLS
LFCR
Founded
2012
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.3M
269.8M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
EOLS
LFCR
Price
$4.01
$3.65
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$15.50
$5.50
AVG Volume (30 Days)
1.5M
404.1K
Earning Date
03-03-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
1.23
N/A
EPS
N/A
N/A
Revenue
$297,176,000.00
$557,559,000.00
Revenue This Year
$13.37
$2.32
Revenue Next Year
$17.56
$11.51
P/E Ratio
N/A
N/A
Revenue Growth
11.61
6.36
52 Week Low
$4.09
$3.86
52 Week High
$12.51
$8.98

Technical Indicators

Market Signals
Indicator
EOLS
LFCR
Relative Strength Index (RSI) 33.01 13.55
Support Level N/A N/A
Resistance Level $4.99 $8.62
Average True Range (ATR) 0.25 0.45
MACD -0.10 -0.14
Stochastic Oscillator 2.33 0.43

Price Performance

Historical Comparison
EOLS
LFCR

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: